[
    "<p><strong>Preparation of reagents</strong></p><p><br></p><p>a.&nbsp;&nbsp;&nbsp;&nbsp;The TSO oligo is reconstituted in \u201cTHE RNA Storage Solution\u201d at a concentration of 1200 \u00b5M. <em>The information sheet from the manufacturer usually provides a dilution volume for a solution with a 100 \u00b5M oligo concentration.",
    "To create the solution with the 1200 \u00b5M oligo concentration, adjust the dilution volume accordingly by reducing 12X times the recommended volume presented on the information sheet</em>.",
    "Then 1 ul is diluted in 99 \u00b5l of RNA storage solution (100X dilution; final concentration: 12 \u00b5M) and stored in aliquots at 5.6 \u00b5l per tube.",
    "The aliquots are stored at -80 \u00b0C.",
    "The TSO ribonucleotides are prone to degradation.",
    "Loss of the ribonucleotides will lead in considerable reduction/absence of cDNA yield.</p><p>b.&nbsp;&nbsp;&nbsp;&nbsp;The PolyT primer is reconstituted in nuclease free H<sub>2</sub>0 at a concentration of 1200 \u00b5M.<em>",
    "The information sheet from the manufacturer usually provides a dilution volume for a solution with a 100 \u00b5M oligo concentration.",
    "To create the solution with the 1200 \u00b5M oligo concentration, adjust the dilution volume accordingly by reducing 12X times the recommended volume presented on the information sheet</em>.",
    "Then 1 \u00b5l is diluted in 99 \u00b5l of nuclease free H<sub>2</sub>0 and stored in aliquots at 7 \u00b5l per tube.",
    "The aliquots can be stored at -80 \u00b0C.&nbsp;</p><p><strong>RNA quantification</strong></p><p><br></p><p>Total RNA can be quantified using the \u201cQubit RNA HS Assay Kit\u201d according to manufacturer instructions.</p><p>&nbsp;</p><p><strong>Assess DNA contamination in the RNA extraction</strong></p><p>&nbsp;</p><p>DNA contamination can be measured using the Qubit dsDNA HS Reagent.</p><p>&nbsp;</p><p><strong>Removal of DNA contamination from total RNA</strong></p><p>Use the DNA-free DNA Removal according to manufacturer instructions for the removal of DNA from RNA samples.</p><p>&nbsp;</p><p><strong>Assess the profile of the extracted RNA</strong></p><p>",
    "Total RNA profile is determined using the Agilent RNA Screentape following manufacturer instructions except that the samples are not heated at 72 \u00b0C.",
    "</p><p><br></p><p><strong>",
    "Spike-In RNA</strong></p><p>ERCC (ERCC RNA Spike-In Mix 1) is added during the cDNA synthesis step.",
    "Aim to obtain a final percentage of 5 % of the reads assigned to ERCCs assuming that ploy(A) fraction of total RNA is 5 %.",
    "Target the sequenced reads of the spiked-in RNA to be 5% of the total amount of sequenced reads).",
    "The amount of spiked RNA (mass<sub>spiked RNA</sub>) that is going to be added in the reaction mix can be calculated as follows:</p><p><br></p><p>mass<sub>(spiked RNA)</sub>=(fraction<sub>(spiked reads)</sub>&nbsp;\u00d7 fraction<sub>(target RNA)</sub>&nbsp;\u00d7 mass<sub>RNAinput</sub>)/Total_RNA_extracted</p><p>where:</p><p>\t<strong>mass </strong><sub><strong>spiked RNA</strong></sub><strong>:</strong> mass (ngs) of spike-in RNA (SIRVs or ERCC) to be added in the sample.</p><p>\t<strong>fraction </strong><sub><strong>spiked reads</strong></sub><strong>:",
    "</strong>desired fraction of sequenced spike-in RNA reads relative to the total amount of sequenced reads.</p><p>\t<strong>fraction </strong><sub><strong>target RNA</strong></sub><strong>:</strong> fraction of the total RNA used in the sample, that is going to be synthesized into cDNA molecules.</p><p>\t<strong>mass </strong><sub><strong>RNA</strong></sub><strong> </strong><sub><strong>input</strong></sub><strong>:</strong> mass (ngs) of RNA input per sample.</p><p><br></p><p>Then the volume (\u00b5l) of spike-in RNA to be used is calculated as follows:&nbsp;</p><p>\t\tvolume<sub>(spike-in RNA) </sub>= mass<sub>(spike-in RNA)</sub>/(concentration<sub>(spike-in RNA)</sub> )</p><p>where</p><p>\t\t<strong>concentration</strong><sub><strong>(spike-in RNA)</strong></sub>: concentration (ngs/\u00b5l) of the spike-in RNAs solution.</p><p>&nbsp;</p><p>\t\t<strong>volume</strong><sub><strong>spike-in RNA</strong></sub><strong>:</strong> volume (\u00b5l) from the spike-in RNAs solution to be added into the sample.</p><p><br></p><p>The value for the \u201cmass <sub>RNA input</sub>\u201d is mass <sub>RNA input</sub> =300 ngs ( 300 ngs of total RNA is used in the cDNA synthesis reactions).",
    "</p><p>&nbsp;</p><p>\t\t\t",
    "For the ERCC RNA Spike-In Mix 1, the <strong>mass </strong><sub><strong>spiked RNA</strong></sub> = 0.45 ngs&nbsp;</p><p>The concentration of the stock solutions are:</p><p>&nbsp;</p><p>\u00b7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The",
    "\u201cERCC RNA Spike-In Mix 1\u201d tube contains 10 \u00b5l of ERCC RNAs at a concentration of 103.515 fmoles/ul or 30.3 ng/\u00b5l .</p><p>&nbsp;</p><p>&nbsp;</p><p>\u00b7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepare",
    "the appropriate dilution of each Spike-In Mix needed.",
    "In the new diluted solution the \u201cmass <sub>spiked RNA</sub>\u201c for either the \u201cERCC RNA Spike-In Mix 1\u201d or the \u201cSpike-in RNA Variant (SIRVs) Control set 3 kit\u201d should correspond, <em>if possible,</em> to 0.1 ul of the final diluted volume.",
    "So we need to have the following dilutions: </p><p>  &nbsp;For the \u201cERCC RNA Spike-In Mix 1\u201d we are going to dilute 6.72 times the stock solution.",
    "So, in 5.72 \u00b5l of \u201cTHE RNA solution\u201d add 1 \u00b5l from the \u201cERCC RNA Spike-In Mix 1\u201d stock solution (new concentration= 4.5 ng/ul).",
    "</p><p>Afterwards we will have to take Volume <sub>spike-in RNA</sub> = ((0.45 ngs)/(4.5 ng/\u00b5l))=0.1 \u00b5l of the diluted solution.</p><p><br></p><p><strong>cDNA",
    "Library generation and sequencing on MinION</strong></p><p>&nbsp;</p><p>Generally, follow the ONT \u201c1D Strand switching cDNA by ligation (SQK-LSK108)\u201d protocol but with custom cDNA synthesis protocol (as described below), and the end repair and d(A) tailing steps are performed separately.",
    "An overview of the protocol as follows:</p><p>&nbsp;</p><p>\t1.&nbsp;&nbsp;&nbsp;&nbsp;cDNA synthesis and amplification</p><p>\t2.&nbsp;&nbsp;&nbsp;&nbsp;End-repair of cDNA molecules</p><p>\t3.&nbsp;&nbsp;&nbsp;&nbsp;dA-tail of cDNA molecules</p><p>\t4.&nbsp;&nbsp;&nbsp;&nbsp;Adapter ligation</p><p>\t5.&nbsp;&nbsp;&nbsp;&nbsp;Sequencing</p><p>\t6.&nbsp;&nbsp;&nbsp;&nbsp;Base-calling</p><p>&nbsp;</p><p><strong>cDNA",
    "synthesis</strong></p><p>Our cDNA synthesis protocol involves a customized version of the Smart-seq protocol<sup>1</sup>.",
    "The protocol is based on the terminal deoxynucleotidyl transferase activity of the wild-type MMLV (Moloney murine leukemia virus) reverse transcriptase<sup>2</sup>.</p><p><br></p><p><strong>Preparation of Master Mixes</strong></p><p><br></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;Thaw and vortex all reagents and keep master mixes on ice until use.",
    "</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;Label",
    "three 1.5 ml eppendorf tubes: \u201c<strong>pre-RT\u201d</strong>, \u201c<strong>RT\u201d</strong>, \u201c<strong>PCR\u201d</strong></p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;Always use fresh TSO primer as it is prone to degradation.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;Prepare the \u201c<strong>pre-RT mix\u201d</strong> according to Table 1 below.&nbsp;</p><p><br></p><p>\tTable 1: <strong>pre-RT mix</strong></p><p>\t\tpre-RT mix&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total RNA (\u00b5l /sample)</p><p>\t",
    "1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ERCC RNA Spike-In Mix 1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;x</p><p>\t2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RNase Inhibitor (40 U/\u00b5L * 125 \u00b5L",
    "= 5000U)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.05</p><p>\t3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Poly-T primer (stock: 12 \u00b5M) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.7</p><p>\t",
    "4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Superscript IV first-strand buffer (5\u00d7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\t&nbsp;&nbsp;0.4</p><p>\t5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nuclease free water&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.19</p><p>\t6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dNTP Mix (stock: 10 mM each) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.56</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong>\t<strong>Total</strong> =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\t\t\t\t\t\t\t2</p><p><br></p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;Pipette 2 \u00b5L of <strong>pre-RT mix </strong>to a PCR tube and add 1uL of sample (<strong>300 ng of total RNA)</strong>.&nbsp;Include a negative control (<strong>1 \u00b5L of water/RNA buffer</strong>).</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;Incubate the samples in a thermocycler set according to Table 2 below.</p><p><br></p><p>\t<strong>Table 2: pre-RT",
    "incubation</strong></p><p>\tTemperature&nbsp;&nbsp;&nbsp;&nbsp;Time&nbsp;&nbsp;&nbsp;&nbsp;\tPurpose</p><p>\t72\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 min&nbsp;&nbsp;&nbsp;Unfolding of RNA secondary structures, Poly-T primer binding</p><p>\t4\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10 min&nbsp;Poly-T primer binds</p><p>\t25\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 min&nbsp;&nbsp;&nbsp;Poly-T primer binds more specifically</p><p>\t4\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hold&nbsp;&nbsp;&nbsp;&nbsp;</p><p><br></p><p>7.",
    "Prepare the \u201c<strong>RT mix</strong> according to Table 3</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\t\t\tRT mix&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\u00b5l /sample</p><p>\t",
    "1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nuclease free H20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.85</p><p>\t",
    "2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Superscript IV first-strand buffer (5\u00d7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\t0.8</p><p>\t3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DTT (stock: 100 mM)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.175</p><p>\t4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TSO (stock: 12 \u03bcM)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.7</p><p>\t5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RNAse inhibitor (stock: 40 U/ \u03bcl)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.175</p><p>\t6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SuperScript IV reverse transcriptase (stock: 200 U/ \u00b5l)&nbsp;&nbsp;&nbsp;&nbsp;\t0.35</p><p>\t7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Betaine (stock: 5 M)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.7</p><p>\t8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MgCl2 (stock: 100 mM)  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.25</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\tTotal =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4</p><p><br></p><p>8.&nbsp;&nbsp;&nbsp;&nbsp;Following pre_RT incubation, add 4 \u00b5l of RT mix to each sample, mix and briefly spin down.</p><p>9.&nbsp;&nbsp;&nbsp;&nbsp;Incubate the samples in a thermocycler set according to Table 4 below</p><p><br></p><p>\tTable 4: <strong>SSIV RT protocol</strong></p><p>\t<strong>Temperature&nbsp;&nbsp;&nbsp;&nbsp;Time&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cycle&nbsp;&nbsp;&nbsp;&nbsp;Purpose</strong></p><p>\t50\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10 min&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RT and template-switching</p><p>\t55\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unfolding of RNA secondary structures</p><p>\t50\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Completion/continuation of RT</p><p>\t60\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unfolding of RNA secondary structures</p><p>\t55\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Completion/continuation of RT</p><p>\t50\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finish template switching</p><p>\t65\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unfolding of RNA secondary structures</p><p>\t60\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Completion/continuation of RT</p><p>\t50\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finish template switching</p><p>\t70\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unfolding of RNA secondary structures</p><p>\t65\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Completion/continuation of RT</p><p>\t50\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finish template switching</p><p>\t75\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unfolding of RNA secondary structures</p><p>\t70\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Completion/continuation of RT</p><p>\t50\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 min&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Final finish template switching</p><p>\t80\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10 min&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enzyme inactivation</p><p>\t4\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hold&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><br></p><p>10.&nbsp;&nbsp;&nbsp;&nbsp;Prepare the <strong>PCR master mix</strong> according to Table 5</p><p>\t<strong>Table 5: PCR master mix</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\t\t<strong>PCR Mix&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(\u00b5l per 7 ul of RT reaction)</strong></p><p>\t1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PCR-Grade Water&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47.6</p><p>\t2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10X Advantage 2 PCR Buffer (Advantage 2 PCR Kit)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7</p><p>\t3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50X dNTP Mix (Advantage 2 PCR Kit) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.8</p><p>\t4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PCR primer (stock: 12 \u03bcM)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.8</p><p>\t",
    "5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50X",
    "Advantage 2",
    "Polymerase Mix (Advantage 2 PCR Kit)   2.8</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\t Total =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63</p><p><br></p><p>11.&nbsp;&nbsp;&nbsp;&nbsp;Following RT incubation, add 63 \u00b5l of PCR mix to each sample, mix and briefly spin down </p><p>12.&nbsp;&nbsp;&nbsp;&nbsp;Incubate",
    "the samples in a thermocycler set according to Table 6 below</p><p><br></p><p>\t<strong>Table 6: PCR protocol</strong></p><p>\t<strong>Temperature&nbsp;&nbsp;&nbsp;&nbsp;Time&nbsp;&nbsp;&nbsp;&nbsp;Cycle</strong></p><p>\t95\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1",
    "min&nbsp;&nbsp;&nbsp;1</p><p>\t95\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20 sec&nbsp;&nbsp;5</p><p>\t58\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 min&nbsp;&nbsp;&nbsp;</p><p>\t68\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6 min&nbsp;&nbsp;&nbsp;</p><p>\t95\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20 sec&nbsp;&nbsp;11 or 12 cycles , aim for ~1-2 \u00b5g of cDNA per 70 \u00b5l of PCR amplification reaction</p><p>\t64\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30 sec&nbsp;&nbsp;</p><p>\t68\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6 min&nbsp;&nbsp;&nbsp;</p><p>\t72\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10 min&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>\t4\u00b0C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hold&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1</p><p><br></p><p>13.&nbsp;&nbsp;&nbsp;The amplified product is subsequently cleaned with Agencourt AMPure XP beads as is described below.",
    "</p><p>\t<strong>Agencourt AMPure XP cleanup of cDNA amplification products</strong></p><p><br></p><p>\ta.&nbsp;&nbsp;&nbsp;&nbsp;Allow",
    "AMPure XP beads to equilibrate to room temperature for at least 30 minutes.</p><p>\tb.&nbsp;&nbsp;&nbsp;&nbsp;Vortex",
    "the beads until evenly mixed, then add 0.9X sample volume of Agencourt AMPure XP beads to the sample in the same tube as used for PCR.</p><p>\tc.&nbsp;&nbsp;&nbsp;&nbsp;Pipet the entire volume up and down to mix thoroughly.",
    "Place the sample tubes on a roler mix for 5 - 8 minutes to let the DNA bind to the beads.",
    "Briefly spin the samples to collect the liquid from the side of the tube.",
    "</p><p>\td.&nbsp;&nbsp;&nbsp;&nbsp;Place the sample tubes on the magnetic separation device for ~2 minutes until the liquid appears completely clear, and there are no beads left in the supernatant.",
    "</p><p>\te.&nbsp;&nbsp;&nbsp;&nbsp;While",
    "the samples are on the magnetic separation device, pipette out the supernatants.&nbsp;Keep the samples on the magnetic separation device.",
    "Add 200 \u03bcl of freshly made 80% ethanol to each sample without disturbing the beads.",
    "Wait for 30 seconds and carefully pipette out the supernatant containing contaminants.",
    "</p><p>\tf.&nbsp;&nbsp;&nbsp;&nbsp;DNA will remain bound to the beads during the washing process.",
    "Repeat step 4 once more.",
    "Briefly spin the samples to collect the liquid from the side of the wall.",
    "</p><p>\tg.&nbsp;&nbsp;&nbsp;&nbsp;Place the samples on the magnetic device for 30 seconds, then remove all the remaining ethanol with a pipette.",
    "</p><p>h.&nbsp;&nbsp;&nbsp;&nbsp;Place",
    "the samples at room temperature until the pellet appears dry (~ 5 minutes).",
    "You may see a tiny crack in the pellet when it is dry.",
    "</p><p>\ti.&nbsp;&nbsp;&nbsp;&nbsp;Once the beads are dry, add 51 \u03bcl of TE buffer to cover the bead pellet.",
    "</p><p>\tj.&nbsp;Remove the samples from the magnetic separation device and mix thoroughly to resuspend the beads.",
    "Incubate the sample with rotation at room temperature for 5 \u2013 8 minutes.</p><p>\tk.&nbsp;Put the tubes on the magnet and after ~2 minutes recover the supernatant which should contain the cleaned amplified cDNA.",
    "Determine the quantity of the cDNA and profile using Qubit HS DNA Assay Kit and Agilent D5000 Tapestation, respectively, following manufacturer instructions.</p><p><br></p><p><br></p><p><strong>End -repair of DNA</strong></p><p>End repair of 1 \u00b5g of amplified cDNA is carried out using NEBNext End Repair Module (New England Biolabs, E6050S) following manufacturer instructions.",
    "This is followed by 0.9X Ampure XP beads cleanup (described above).</p><p><br></p><p><strong>dA-tailing reaction</strong></p><p>d(A) tailing of the recovered end-repaired cDNA is carried out using NEBNext dA-Tailing Module (New England Biolabs, E6053S) following manufacturer instructions.",
    "This is followed by 0.9X Ampure XP beads cleanup (described above).</p><p><strong>Adapter ligation</strong></p><p>Ligation of ONT sequencing adapters onto recovered d(A)-tailed cDNA (up to 1 \u00b5g) is carried out following ONT SQK-LSK-108 protocol.",
    "However, you can increase the incubation time from 10 minutes to 1 - 4 hours at room temperature.</p><p><strong>ONT MinION sequencing kit</strong></p><p>ONT SQK-LSK-108 protocol is followed for the sequencing part.</p><p><strong>Basecalling</strong></p><p>Basecalling can be done off-line using Albacore from ONT</p><p><br></p><p><strong>Data analysis example commandline arguments</strong></p><p>",
    "Basecalling </p><p>Albacore (ONT, version 2.0.2)</p><p>read_fast5_basecaller.py -r --flowcell SQK-LSK108 --kit SQK-LSK108 --input",
    "%s --save_path %s --worker_threads 23",
    "-o fastq\" %(input_dir,save_path))</p><p><br></p><p>Minionqc<sup>3</sup> (version 1.0)</p><p>Rscript ~/MinionQC.R -p 23 -i $(\u2018pwd\u2019)/files -o $(\u2018pwd\u2019)/results</p><p><br></p><p>Pauvre (version 0.1.2, https://github.com/conchoecia/pauvre)</p><p>pauvre marginplot --no-transparent --fastq ../Bo_E_1H_C010_10_pass.fastq &gt; pauvre.out 2&gt; pauvre.out</p><p><br></p><p>Porechop (version 0.2.3, https://github.com/rrwick/Porechop)</p><p>~/porechop --format fasta -t 47 -i $read5.fasta -o $read5.choped.fasta &gt; porechop.stdout 2&gt; porechop.stdout</p><p><br></p><p>Cutadapt<sup>4</sup> poly(A) trimming from read ends (version 1.15)</p><p>~/.local/bin/cutadapt --info-file=trim_info -f fasta -a",
    "\"A[100]\" -o $read2.cutadapt.fasta $read2.fasta</p><p><br></p><p>GMAP<sup>5</sup> (version 2018-03-25)</p><p>GMAP for alignment QC</p><p>~/gmap",
    "-t 23 -D $dirc -f",
    "samse -d $ref $read1 &gt; $outsam.sam</p><p><br></p><p>GMAP for transcriptome",
    "assembly</p><p>~/gmap -t 23 -D $dirc --cross-species --max-intronlength-ends=10000 -n 1 -z sense_force -f",
    "samse -d $ref $read1 &gt; $outsam1.sam 2&gt; gmap.stdout</p><p><br></p><p>Minimap2<sup>6</sup> (version 2.9 (r720))</p><p>~/minimap2 -ax splice",
    "-t 23 $ref $reads1 &gt; $outsam1.sam</p><p><br></p><p>Samtools<sup>7</sup> (version 1.3.2)</p><p><br></p><p>AlignQC<sup>8</sup> (version 1.2)</p><p>~/alignqc analyze $outsam1.sort.bam --specific_tempdir $dirc/tmp1 -r $ref -a $annotation -o alignqc.xhtml --output_folder $dirc/alignQC.ouput_b4_correction &gt; alignqc.stdout</p><p><br></p><p>Canu<sup>9</sup> (Canu 1.7)</p><p>canu useGrid=false -correct gnuplotImageFormat=png corOutCoverage=10000 corMhapSensitivity=high corMinCoverage=0 correctedErrorRate=0.16 overlapper=minimap ovsMethod=sequential minReadLength=200 minOverlapLength=100 genomeSize=1500000000 -p Bo_E_all_pass_edited -d Bo_E_all_pass_edited -nanopore-raw Bo_E_all_pass_edited.fasta</p><p><br></p><p>LoRDEC<sup>10</sup> (v0.8, using GATB v1.4.1)</p><p><br></p><p>~/lordec-correct -2",
    "$illumina_reads -T 47 -p -k 19 -s 3 -i $nanopore.fasta -o \"$nanopore\"_lordec_corrected.fasta</p><p><br></p><p>GFOLD<sup>11</sup> (v1.1.4)</p><p>gfold diff -norm",
    "NO -s1 Bo.E.2H",
    "-s2 Bo.",
    "E.1H -suf",
    ".abs_cnt3",
    "-o Bo.E.2HvsBo.E.1H.abs.diff &gt; Bo.E.2HvsBo.",
    "E.1H.abs.diff.stdout</p><p><br></p><p>cDNA_Cupcake (version 5.3, https://github.com/Magdoll/cDNA_Cupcake/wiki)</p><p>~/collapse_isoforms_by_sam.py --input $read1 -s",
    "$outsam.sorted.sam --dun-merge-5-shorter -o $pref</p><p>~/filter_by_count.py $pref.collapsed --min_count=2 &gt;filter_by_count.stdout</p><p>~/filter_away_subset.py $pref.collapsed &gt;filter_away_subset.stdout</p><p>~/filter_away_subset.py $pref.collapsed.min_fl_2</p><p>cDNA_Cupcake for assembly evaluation using 5-hour",
    "timepoint</p><p>~/collapse_isoforms_by_sam.py -c",
    "0.95 -i 0.95 --input",
    "$read1 -s",
    "$sortedsam --dun-merge-5-shorter -o $pref</p><p><br></p><p>TAMA (version tc0.0, https://github.com/GenomeRIK/tama)</p><p>~/tama_collapse.py -d",
    "merge_dup -s",
    "$sortedsam -f",
    "$ref -p $pref -x no_cap -c 95",
    "-i 95</p><p><br></p><p>TAPIS<sup>12</sup> (1.2.1)</p><p>alignPacBio.py -p",
    "22 -v -K 10000",
    "-o tapis_output $indexesDir $indexName $reference $reads</p><p>run_tapis.py -p",
    "-t 30 -o run_tapis_output $annotation tapis_output/$bamfile</p><p><br></p><p>SQANTI<sup>13</sup> (version 1.2)</p><p>sqanti_qc.py -z",
    "-t 47 -fl $fl_abundance -c $sj_covIllumina -e $isoExpression -x $gmapindex -o $output -d qc_output $isoforms.fa $gtf $ref</p><p>sqanti_filter.py -d filter_output&nbsp;-i \"$isoforms\"_corrected.fasta \"$output\"_classification.txt</p><p><br></p><p><br></p>"
]